New Melanoma Drug, Tudriqev, Based On Herpes Virus Granted FDA Accelerated Approval

MONDAY, Aug. 10, 2026 — Federal regulators have granted accelerated approval to a novel therapy for advanced melanoma — giving doctors another weapon to fight this challenging skin cancer.
Tudriqev is an oncolytic viral therapy, which...